Emblem Corp Share Price

Equities

EMC

CA29082J1084

Pharmaceuticals

End-of-day quote Toronto S.E. 01:29:45 19/03/2019 am IST 5-day change 1st Jan Change
1.88 CAD +1.62% Intraday chart for Emblem Corp +1.62% +106.59%

Financials

Sales 2017 2.69 3.68 224.62 Sales 2018 8.22 11.23 685.62 Capitalization 119M 162M 9.91B
Net income 2017 -12M -16.39M -1B Net income 2018 -24M -32.79M -2B EV / Sales 2017 7,23,52,077 x
Net cash position 2017 21.51M 29.39M 1.79B Net cash position 2018 29.05M 39.69M 2.42B EV / Sales 2018 1,09,15,686 x
P/E ratio 2017
-16.3 x
P/E ratio 2018
-4.48 x
Employees -
Yield 2017 *
-
Yield 2018
-
Free-Float 98.36%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - -
President - 01/17/01
Director/Board Member - -
Members of the board TitleAgeSince
Director/Board Member 42 -
Director/Board Member - 06/18/06
Director/Board Member - -
More insiders
Emblem Corp is a Canada-based Company engaged in alternative medicine sector. The Company is producer and distributor of medical cannabis and cannabis derivatives licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company operates in one segment, the production and sale of medical cannabis to patients who have received medical authorizations to acquire and use cannabis. The Company offers fully integrated services covering the full cannabis spectrum, from growing to selling, as well as educating and also creating new forms of cannabinoid-based medication in standardized dosages. All of the Company’s assets are located in Canada.
More about the company